AUS
NZ
UK
CA
USA
IND
Healthcare
Cochlear (ASX:COH) in Spotlight: Key Insights Driving ASX 200 Growth
September 04, 2025 10:23 AM AEST| By Team Kalkine MediaDiscover how Cochlear (ASX:COH), a global leader in hearing solutions, strengthens its position in the ASX 200 with strong fundamentals and innovative healthcare advancements.
Cochlear (ASX:COH) delivers consistent five-year returns ASX 100
September 03, 2025 06:25 PM AEST| By Team Kalkine MediaHighlights,Cochlear's performance aligns with strong earnings progression over recent years,Company continues to maintain consistency across dividends and share value,ASX 100 stock shows steady sentiment reflected in long-term shareholder returns,Coc...
Integral Diagnostics (ASX:IDX) Earnings Show Mixed Signals Amid Dilution ASX 300 Watch
September 03, 2025 06:17 PM AEST| By Team Kalkine MediaHighlights,Integral Diagnostics (ASX:IDX) reports earnings influenced by a sharp increase in issued shares,Earnings per share diluted significantly due to expanded capital base,One-off items played a major role in shaping the net profit outcome,Integ...
ASX 200 Botanix Pharmaceuticals (ASX:BOT) Sees Ownership Strain Amid Market Dip
September 03, 2025 04:29 PM AEST| By Team Kalkine MediaHighlights,Botanix Pharmaceuticals’ ownership is dominated by individual shareholders with a broad spread,Institutional investors have significant influence but not majority control,Insider ownership reflects leadership involvement in equity holding,...
4DMedical (ASX: 4DX) Surges on U.S. Reimbursement Breakthrough ASX 300
September 03, 2025 04:22 PM AEST| By Team Kalkine MediaHighlights,4DMedical receives U.S. reimbursement approval for its lung imaging software CT:VQ.,Medicare backing confirms both regulatory and commercial viability of the company’s technology.,New milestone could accelerate hospital adoption and broade...
Argenica Therapeutics (ASX:AGN) Faces Clinical Setback Can Subgroup Results Provide Direction?
September 03, 2025 02:36 PM AEST| By Team Kalkine MediaHighlights,Argenica Therapeutics reported topline data from its stroke treatment trial, showing no broad efficacy.,Subgroup findings revealed a signal of reduced brain tissue damage in patients with slower collateral blood flow.,Market sentiment shif...
Pro Medicus (ASX:PME) Strengthens Healthcare Tech Role with ASX 200 Spotlight
September 03, 2025 12:54 PM AEST| By Team Kalkine MediaExplore how Pro Medicus (ASX:PME) drives innovation in healthcare technology, its strong positioning in the ASX 200, and why the healthcare sector continues to attract global attention.
Argenica Therapeutics (ASX:AGN) Advances Stroke Drug with Phase 2 Safety Data
September 03, 2025 12:50 PM AEST| By Team Kalkine MediaArgenica Therapeutics (ASX:AGN) reports encouraging safety results for its stroke therapy ARG-007 in Phase 2 trials, marking progress toward future development stages.
Which ASX 200 Healthcare Stock Could Offer More Value in 2025?
September 03, 2025 10:30 AM AEST| By Team Kalkine MediaA detailed look at CSL Ltd (ASX:CSL) and Pro Medicus Ltd (ASX:PME), exploring their business strengths, industry roles, and potential value in 2025.
Neurizon Therapeutics Market Position and Developments in the Biotechnology Sector
September 02, 2025 09:09 PM AEST| By Team Kalkine MediaHighlights,Neurizon Therapeutics is positioned in the biotechnology sector with evolving market dynamics.,The company has experienced contrasting shifts in performance despite challenges in operational progress.,Its inclusion within a major Australia...
Ramsay Health Care (ASX:RHC) Declares Dividend as Focus Remains on Cash Flow Strength
September 02, 2025 06:13 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care (ASX:RHC) declared a dividend, highlighting reliance on steady cash flows,Dividend history shows reductions compared with prior years, limiting long-term growth consistency,Earnings trends remain weak, but forecasts indi...
Ramsay Health Care (ASX:RHC) Declares Dividend as Focus Remains on Cash Flow Strength
September 02, 2025 06:04 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care (ASX:RHC) declared a dividend, highlighting reliance on steady cash flows,Dividend history shows reductions compared with prior years, limiting long-term growth consistency,Earnings trends remain weak, but forecasts indi...
Sonic Healthcare (ASX:SHL) Share Price Outlook – What the ASX 200 Investor Should Know
September 02, 2025 06:01 PM AEST| By Team Kalkine MediaExplore Sonic Healthcare (ASX:SHL) share price insights, financial health, and valuation outlook as one of the major players in the ASX 200 healthcare sector.
Healthcare Stumbles While Materials Surge in ASX August Trade
September 02, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,S&P/ASX 200 posted steady gains through August with resilience across most sectors,Healthcare dragged lower as CSL (ASX:CSL) recorded a historic daily fall,Rare earths explorer Kaili Resources (ASX:KLR) soared, driving momentum in small-ca...
Race Oncology Expands RC220 Trial in Hong Kong with Focus on Advanced Solid Tumours
September 02, 2025 11:01 AM AEST| By Team Kalkine MediaRace Oncology (ASX:RAC) advances its RC220 trial with the first Hong Kong site activation, strengthening its clinical research efforts in advanced solid tumours.
Santos (ASX:STO) takeover sparks ASX 200 volatility amid state scrutiny
September 01, 2025 04:49 PM AEST| By Team Kalkine MediaHighlights,South Australian government to evaluate the Abu Dhabi-led acquisition of Santos,Ministerial approval required for change in controlling interest for licence holders,Share price movement reflects heightened investor attention on Santos' ope...
Is ASX:MX1 financially exposed? Micro-X debt scrutiny raises questions ASX 300
September 01, 2025 04:19 PM AEST| By Team Kalkine MediaHighlights:,Micro-X (ASX:MX1), listed on the,ASX 300,, has taken on debt after previously holding none.,The company’s liabilities exceed its combined short-term cash and receivables.,Revenue contraction and cash outflows mark challenges ahead for the...
How Alterity Therapeutics (ASX:ATH) Is Managing Growth Amid Cash Flow Questions ASX 300
September 01, 2025 04:05 PM AEST| By Team Kalkine MediaHighlights,Alterity Therapeutics (ASX:ATH) operates in the biotechnology sector, currently listed on the,ASX 300,index.,The company has reported a decrease in cash burn over the past year, signaling operational discipline.,Despite being pre-revenue,...
Insider Buying in ReNerve (ASX:RNV) Faces Value Strain Despite Ownership Confidence All Ordinaries
September 01, 2025 03:29 PM AEST| By Team Kalkine MediaHighlights,Insider share purchases in ReNerve have not recovered from their original costs despite recent price movements,The company’s Independent Chairman previously acquired shares at significantly higher levels,ReNerve insiders hold a considerabl...
Is Micro-X (ASX:MX1) Carrying Too Much Financial Strain?
September 01, 2025 02:59 PM AEST| By Team Kalkine MediaMicro-X (ASX:MX1) reported short-term liabilities exceeding cash reserves and receivables Company continues to operate with a net debt balance and negative EBIT performance Revenues have declined while the business faces balance sheet pressures
Advertise your brand on Kalkine Media